Skeletal muscle lymphocytic vasculitis in systemic lupus erythematosus: relation to disease activity.
Lymphocytic vasculitis (LV) characterises systemic lupus erythematosus (SLE) and this potentially reversible lesion, which may be subclinical, may imply overt systemic disease activity. Needle quadriceps muscle biopsy was performed in 26 unselected patients with SLE and the presence of LV in these muscle specimens was compared with SLE disease activity scored using the British Isles Lupus Assessment Group Index (BILAG). Ten of the 22 patients with active disease showed evidence of LV compared with none of the four patients with inactive disease. In the patient group with LV, significantly higher ESR and urine neopterin values were found with P = 0.002 and P = 0.02, respectively compared with patients without LV. Features of vasculitis (as defined by BILAG) were also significantly more common in these patients (P = 0.005). None of the other parameters, including creatine kinase, were significantly different between the two patient subgroups. Thus, LV in needle quadriceps muscle biopsy specimens is a further valuable marker of disease activity in patients with SLE and might provide histological evidence of a systemic vasculitic process in a group of patients with diverse clinical manifestations.
Lim
K L
KL
Department of Immunology, University Hospital, Queens Medical Centre, Nottingham, UK.
Lowe
J
J
Powell
R J
RJ
D000328:Adult; D001706:Biopsy; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000473:pathology*; D008875:Middle Aged; D018482:Muscle, Skeletal / Q000473:pathology*; D014657:Vasculitis / Q000473:pathology*